Welcome: Guest | Register | Login |

Ridge Diagnostics, Inc. and Ameritox, Ltd. Enter into Licensing Agreement for Depression Biomarker Blood Test

Awardee Story Ridge Diagnostics, Inc. and Ameritox, Ltd. Enter into Licensing Agreement for Depression Biomarker Blood Test
Date: Apr 05, 2012

Source: BusinessWeek

Ridge Diagnostics, Inc. announced it has entered into an exclusive agreement with Ameritox Ltd. for the license rights to its proprietary developmental blood test MDDScore (TM), a multiple biomarker analysis for Major Depressive Disorder (MDD) for primary care and pain physicians. As part of the agreement, Ameritox has agreed to make an undisclosed equity investment in Ridge and commit to a next-stage clinical development program.

The MDDScore test developed by Ridge Diagnostics measures ten biomarker levels associated with factors such as inflammation, development and maintenance of neurons and interaction between brain structures involved with stress response and other key biological functions. Measurements are analyzed to produce an MDDScore which may help physicians determine whether a patient has major depression.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com